vs
Side-by-side financial comparison of CHART INDUSTRIES INC (GTLS) and Hologic (HOLX). Click either name above to swap in a different company.
CHART INDUSTRIES INC is the larger business by last-quarter revenue ($1.1B vs $1.0B, roughly 1.0× Hologic). Hologic runs the higher net margin — 17.1% vs 5.0%, a 12.1% gap on every dollar of revenue. On growth, Hologic posted the faster year-over-year revenue change (2.5% vs -2.5%). Hologic produced more free cash flow last quarter ($215.2M vs $66.2M). Over the past eight quarters, CHART INDUSTRIES INC's revenue compounded faster (6.6% CAGR vs 1.5%).
Oricon Inc. , established in 1999, is the holding company at the head of a Japanese corporate group that supplies statistics and information on music and the music industry in Japan and Western music. It started as Original Confidence Inc. , which was founded by Sōkō Koike in November 1967 and became known for its music charts. Oricon Inc. was originally set up as a subsidiary of Original Confidence and took over the latter's Oricon record charts in April 2002.
Hologic, Inc. is an American medical technology company primarily focused on women's health; it sells medical devices for diagnostics, surgery, and medical imaging.
GTLS vs HOLX — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.1B | $1.0B |
| Net Profit | $53.6M | $179.1M |
| Gross Margin | 33.3% | 56.0% |
| Operating Margin | 11.6% | 22.6% |
| Net Margin | 5.0% | 17.1% |
| Revenue YoY | -2.5% | 2.5% |
| Net Profit YoY | -32.7% | -10.9% |
| EPS (diluted) | $1.06 | $0.79 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.1B | $1.0B | ||
| Q3 25 | $1.1B | $1.0B | ||
| Q2 25 | $1.1B | $1.0B | ||
| Q1 25 | $1.0B | $1.0B | ||
| Q4 24 | $1.1B | $1.0B | ||
| Q3 24 | $1.1B | $988.0M | ||
| Q2 24 | $1.0B | $1.0B | ||
| Q1 24 | $950.7M | $1.0B |
| Q4 25 | $53.6M | $179.1M | ||
| Q3 25 | $-138.5M | $187.2M | ||
| Q2 25 | $76.1M | $194.9M | ||
| Q1 25 | $49.5M | $-17.4M | ||
| Q4 24 | $79.6M | $201.0M | ||
| Q3 24 | $69.0M | $178.6M | ||
| Q2 24 | $58.6M | $194.5M | ||
| Q1 24 | $11.3M | $169.9M |
| Q4 25 | 33.3% | 56.0% | ||
| Q3 25 | 34.1% | 55.6% | ||
| Q2 25 | 33.6% | 56.3% | ||
| Q1 25 | 33.9% | 37.5% | ||
| Q4 24 | 33.6% | 56.8% | ||
| Q3 24 | 34.1% | 56.4% | ||
| Q2 24 | 33.8% | 55.4% | ||
| Q1 24 | 31.8% | 53.3% |
| Q4 25 | 11.6% | 22.6% | ||
| Q3 25 | -8.0% | 22.6% | ||
| Q2 25 | 15.7% | 24.9% | ||
| Q1 25 | 15.2% | -0.7% | ||
| Q4 24 | 17.0% | 22.5% | ||
| Q3 24 | 16.8% | 23.3% | ||
| Q2 24 | 16.1% | 24.1% | ||
| Q1 24 | 11.9% | 20.7% |
| Q4 25 | 5.0% | 17.1% | ||
| Q3 25 | -12.6% | 17.8% | ||
| Q2 25 | 7.0% | 19.0% | ||
| Q1 25 | 4.9% | -1.7% | ||
| Q4 24 | 7.2% | 19.7% | ||
| Q3 24 | 6.5% | 18.1% | ||
| Q2 24 | 5.6% | 19.2% | ||
| Q1 24 | 1.2% | 16.7% |
| Q4 25 | $1.06 | $0.79 | ||
| Q3 25 | $-3.23 | $0.84 | ||
| Q2 25 | $1.53 | $0.86 | ||
| Q1 25 | $0.94 | $-0.08 | ||
| Q4 24 | $1.57 | $0.87 | ||
| Q3 24 | $1.33 | $0.75 | ||
| Q2 24 | $1.10 | $0.82 | ||
| Q1 24 | $0.10 | $0.72 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $366.0M | $2.4B |
| Total DebtLower is stronger | $3.7B | $2.5B |
| Stockholders' EquityBook value | $3.2B | $5.2B |
| Total Assets | $9.8B | $9.2B |
| Debt / EquityLower = less leverage | 1.13× | 0.48× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $366.0M | $2.4B | ||
| Q3 25 | $399.2M | $2.2B | ||
| Q2 25 | $342.3M | $1.9B | ||
| Q1 25 | $296.2M | $1.6B | ||
| Q4 24 | $308.6M | $2.0B | ||
| Q3 24 | $310.2M | $2.3B | ||
| Q2 24 | $247.4M | $2.4B | ||
| Q1 24 | $191.9M | $2.2B |
| Q4 25 | $3.7B | $2.5B | ||
| Q3 25 | — | $2.5B | ||
| Q2 25 | — | $2.5B | ||
| Q1 25 | — | $2.5B | ||
| Q4 24 | $3.8B | $2.5B | ||
| Q3 24 | — | $2.5B | ||
| Q2 24 | — | $2.5B | ||
| Q1 24 | — | $2.6B |
| Q4 25 | $3.2B | $5.2B | ||
| Q3 25 | $3.2B | $5.0B | ||
| Q2 25 | $3.4B | $4.8B | ||
| Q1 25 | $3.0B | $4.6B | ||
| Q4 24 | $2.8B | $4.8B | ||
| Q3 24 | $3.0B | $5.1B | ||
| Q2 24 | $2.7B | $5.0B | ||
| Q1 24 | $2.7B | $4.8B |
| Q4 25 | $9.8B | $9.2B | ||
| Q3 25 | $9.8B | $9.0B | ||
| Q2 25 | $9.7B | $8.8B | ||
| Q1 25 | $9.3B | $8.5B | ||
| Q4 24 | $9.1B | $8.7B | ||
| Q3 24 | $9.5B | $9.2B | ||
| Q2 24 | $9.3B | $8.9B | ||
| Q1 24 | $9.2B | $8.7B |
| Q4 25 | 1.13× | 0.48× | ||
| Q3 25 | — | 0.50× | ||
| Q2 25 | — | 0.52× | ||
| Q1 25 | — | 0.55× | ||
| Q4 24 | 1.33× | 0.53× | ||
| Q3 24 | — | 0.49× | ||
| Q2 24 | — | 0.51× | ||
| Q1 24 | — | 0.53× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $88.8M | $229.9M |
| Free Cash FlowOCF − Capex | $66.2M | $215.2M |
| FCF MarginFCF / Revenue | 6.1% | 20.5% |
| Capex IntensityCapex / Revenue | 2.1% | 1.4% |
| Cash ConversionOCF / Net Profit | 1.66× | 1.28× |
| TTM Free Cash FlowTrailing 4 quarters | $202.8M | $1.0B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $88.8M | $229.9M | ||
| Q3 25 | $118.0M | $355.1M | ||
| Q2 25 | $145.9M | $343.3M | ||
| Q1 25 | $-60.0M | $169.4M | ||
| Q4 24 | $281.4M | $189.3M | ||
| Q3 24 | $200.6M | $367.0M | ||
| Q2 24 | $116.1M | $405.8M | ||
| Q1 24 | $-95.1M | $292.4M |
| Q4 25 | $66.2M | $215.2M | ||
| Q3 25 | $94.7M | $341.4M | ||
| Q2 25 | $122.0M | $330.5M | ||
| Q1 25 | $-80.1M | $153.9M | ||
| Q4 24 | $260.9M | $172.5M | ||
| Q3 24 | $174.5M | $350.6M | ||
| Q2 24 | $88.0M | $385.3M | ||
| Q1 24 | $-141.2M | $279.6M |
| Q4 25 | 6.1% | 20.5% | ||
| Q3 25 | 8.6% | 32.5% | ||
| Q2 25 | 11.3% | 32.3% | ||
| Q1 25 | -8.0% | 15.3% | ||
| Q4 24 | 23.6% | 16.9% | ||
| Q3 24 | 16.4% | 35.5% | ||
| Q2 24 | 8.5% | 38.1% | ||
| Q1 24 | -14.9% | 27.5% |
| Q4 25 | 2.1% | 1.4% | ||
| Q3 25 | 2.1% | 1.3% | ||
| Q2 25 | 2.2% | 1.3% | ||
| Q1 25 | 2.0% | 1.5% | ||
| Q4 24 | 1.9% | 1.6% | ||
| Q3 24 | 2.5% | 1.7% | ||
| Q2 24 | 2.7% | 2.0% | ||
| Q1 24 | 4.8% | 1.3% |
| Q4 25 | 1.66× | 1.28× | ||
| Q3 25 | — | 1.90× | ||
| Q2 25 | 1.92× | 1.76× | ||
| Q1 25 | -1.21× | — | ||
| Q4 24 | 3.54× | 0.94× | ||
| Q3 24 | 2.91× | 2.05× | ||
| Q2 24 | 1.98× | 2.09× | ||
| Q1 24 | -8.42× | 1.72× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GTLS
| Repair Service And Leasing Segment | $330.4M | 31% |
| Heat Transfer Systems Segment | $325.8M | 30% |
| Specialty Products Segment | $259.5M | 24% |
| Transferred Over Time | $94.4M | 9% |
| Transferred At Point In Time | $69.5M | 6% |
HOLX
| Molecular Diagnostics | $255.3M | 24% |
| Breast Imaging | $219.9M | 21% |
| Services | $216.4M | 21% |
| Capital Equipment Componentsand Software | $187.2M | 18% |
| Cytology Perinatal | $76.0M | 7% |
| Interventional Breast Solutions | $71.2M | 7% |
| Blood Screening | $8.4M | 1% |
| Other Typeof Revenue | $5.4M | 1% |
